Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name H19
   Synonyms H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2
   Region GRCh38_11:1995176-2001470    Sequence
   Ensembl ENSG00000130600
   RefSeq NR_002196
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name clear cell renal cell carcinoma
   ICD-0-3 C64.9  M8005/0
   Methods qPCR, Luciferase reporter assay, Western blot, RIP, RNAi
   Sample clear cell renal cell carcinoma tissues, cell lines (786-O)
   Expression Pattern up-regulated
   Function Description

lncRNA-H19 was high expressed and negatively correlated with miR-29a-3p in ccRCC.miR-29a-3p was identified as a direct target of lncRNA-H19. down-regulated lncRNA-H19 could affect the expression of miR-29a-3p targeting E2F1 with competitively binding miR-29a-3p.lncRNA-H19 knockdown inhibited cells migration and invasion, but this effect was attenuated by co-transfection of lncRNA-H19 siRNA and miR-29a-3p inhibitor. Over expression of E2F1 could rescue lncRNA-H19 siRNA induced suppression on cell migration and invasion in ccRCC cells.These results show a possible competing endogenous RNAs regulatory network involving lncRNA-H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in ccRCC.

   Pubmed ID 29214011
   Year 2017
   Title Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
   External Links
   Links for  H19 GenBank       HGNC       lncrnadb       Noncode
   Links for  clear cell renal cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.